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Background
Proteochemometrics (PCM) is a predictive bioactivity
modelling method which simultaneously models the
bioactivity of multiple ligands against multiple targets.
PCM permits exploration of the selectivity and promiscu-
ity of ligands on biomolecular systems of different com-
plexity. This includes proteins and even cell-line models
[1,2]. The suitability of PCM to predict compound poly-
pharmacology has been validated both retrospectively and
in prospective experimental validation [1,2]. In practice,
each ligand-target interaction is encoded by the concate-
nation of ligand and target descriptor vectors used to train
a single machine learning model. The inclusion of both
chemical and target information enables the extra- and
interpolation on the chemical and on the biological space.
Therefore, PCM permits to predict compound bioactivities
on targets not present in the training phase [3].
Results
In this contribution, we show a methodological advance-
ment in the field [4], namely how Bayesian inference
(Gaussian Processes) can be successfully applied in the
context of PCM for (i) the prediction of compound
bioactivity along with the error estimation of the predic-
tion; (ii) the determination of the applicability domain
of a PCM model; and (iii) the inclusion of experimental
uncertainty of bioactivity measurements. We illustrate
how the application of PCM can be useful in medicinal
chemistry to concomitantly optimize compounds
selectivity and potency, in the context of two application
scenarios: (a) modelling isoform-selective cyclooxygenase
inhibition; and (b) large-scale cancer cell line drug sensi-
tivity prediction, where we benchmark the predictive
signal of basal gene expression, gene copy-number varia-
tion, exome sequencing, and protein abundance data.
We present the R package Chemically Aware Model
Builder (camb) [5], which is able to perform the above
mentioned modelling tasks. camb is an open source
platform for the generation of Structure-Activity and
Structure-Property models. The functionalities of camb
include: (i) standardisation of chemical structure repre-
sentation, (ii) calculation of 905 one-dimensional
descriptors and 14 fingerprints for small molecules, (iii)
8 types of amino acid descriptors, (iv) 13 whole protein
sequence descriptors, and (iv) training, validation and
visualization of predictive models.
Conclusions
Overall, the application of PCM in these two case sce-
narios let us conclude that PCM is a suitable technique,
on this data, to model the activity of ligands exhibiting
diverse bioactivity profiles across a panel of targets,
which can range from protein binding sites (a), to can-
cer cell-lines (b). The camb package constitutes a plat-
form encompassing all steps for the generation of
predictive models from chemical structures and their
associated bioactivities/properties, which will provide
reproducibility and simplify the generation of predictive
bioactivity/property models.
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